{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:00:07Z","timestamp":1785114007405,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Talent Introduction Project of Hubei Polytechnic University","award":["21xjz33R"],"award-info":[{"award-number":["21xjz33R"]}]},{"name":"the Talent Introduction Project of Hubei Polytechnic University","award":["21xjz34R"],"award-info":[{"award-number":["21xjz34R"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203934"],"award-info":[{"award-number":["82203934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272356"],"award-info":[{"award-number":["82272356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Talent Project of First Affiliated Hospital of Kunming Medical University","award":["2025535Q01"],"award-info":[{"award-number":["2025535Q01"]}]},{"name":"Yunnan Provincial Clinical Medical Center","award":["2024YNLCYXZX0027"],"award-info":[{"award-number":["2024YNLCYXZX0027"]}]},{"name":"the Key research and development program of Yunnan Province","award":["202403AC100011"],"award-info":[{"award-number":["202403AC100011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13149-1","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:05:21Z","timestamp":1778162721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effective treatment of scabetic nodules with thalidomide: a 5-year retrospective case series"],"prefix":"10.1186","volume":"26","author":[{"given":"Rong-Jing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Wang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"1","key":"13149_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-024-00552-8","volume":"10","author":"DD Fernando","year":"2024","unstructured":"Fernando DD, Mounsey KE, Bernigaud C, Surve N, Estrada Ch\u00e1vez GE, Hay RJ, Currie BJ, Chosidow O, Fischer K. Scabies[J]. Nat reviews Disease primers. 2024;10(1):74.","journal-title":"Nat reviews Disease primers"},{"issue":"1","key":"13149_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/22221751.2020.1754136","volume":"9","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, Zeng W, Lu H. Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017[J]. Emerg microbes infections. 2020;9(1):813\u20136.","journal-title":"Emerg microbes infections"},{"key":"13149_CR3","doi-asserted-by":"crossref","unstructured":"Gupta S, Thornley S, Morris A, Sundborn G, Grant C. Prevalence and determinants of scabies: a global systematic review and meta-analysis[J]. Tropical medicine & international health: TM & IH. 2024;29(12):1006-17.","DOI":"10.1111\/tmi.14058"},{"issue":"6","key":"13149_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00403-024-03046-5","volume":"316","author":"Y Kong","year":"2024","unstructured":"Kong Y, Xing P, Huai P, Zhang F. The burden of skin diseases in China: global burden of Disease Study 2019[J]. Arch Dermatol Res. 2024;316(6):277.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"13149_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/jama.2018.7480","volume":"320","author":"M Tarbox","year":"2018","unstructured":"Tarbox M, Walker K, Tan M. Scabies[J]. JAMA. 2018;320(6):612.","journal-title":"JAMA"},{"issue":"3","key":"13149_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.det.2018.02.009","volume":"36","author":"A Jannic","year":"2018","unstructured":"Jannic A, Bernigaud C, Brenaut E, Chosidow O. Scabies Itch[J]. Dermatol Clin. 2018;36(3):301\u20138.","journal-title":"Dermatol Clin"},{"issue":"4","key":"13149_CR7","first-page":"115","volume":"16","author":"D Blakey","year":"1975","unstructured":"Blakey D, Editorials. Scabies: the itch[J]. J Miss State Med Assoc. 1975;16(4):115\u20136.","journal-title":"J Miss State Med Assoc"},{"key":"13149_CR8","doi-asserted-by":"crossref","unstructured":"Yanes DA, Faith EF. Nodular scabies: a persistent nodular eruption[J]. Dermatol Online J. 2018;24(8).","DOI":"10.5070\/D3248041135"},{"issue":"2 Suppl","key":"13149_CR9","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jaad.2007.04.006","volume":"57","author":"B Tesner","year":"2007","unstructured":"Tesner B, Williams NO, Brodell RT. The pathophysiologic basis of scabietic nodules[J]. J Am Acad Dermatol. 2007;57(2 Suppl):S56\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"13149_CR10","first-page":"157","volume":"64","author":"RR Mittal","year":"1998","unstructured":"Mittal RR, Jain C, Jindal R. Treatment of nodular scabies (le)[J]. Indian J Dermatol Venereol Leprol. 1998;64(3):157\u20138.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"13149_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/blood.2019001420","volume":"134","author":"P Neri","year":"2019","unstructured":"Neri P. The Pandora\u2019s box of thalidomide analogs and their substrates[J]. Blood. 2019;134(2):105\u20136.","journal-title":"Blood"},{"issue":"1","key":"13149_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaad.2016.03.022","volume":"75","author":"Z Nahmias","year":"2016","unstructured":"Nahmias Z, Nambudiri VE, Vleugels RA. Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions[J]. J Am Acad Dermatol. 2016;75(1):210\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"9423","key":"13149_CR13","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","volume":"363","author":"ME Franks","year":"2004","unstructured":"Franks ME, Macpherson GR, Figg WD. Thalidomide[J]. Lancet. 2004;363(9423):1802\u201311.","journal-title":"Lancet"},{"issue":"6","key":"13149_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s10067-016-3256-3","volume":"35","author":"D Wang","year":"2016","unstructured":"Wang D, Chen H, Wang S, Zou Y, Li J, Pan J, Wang X, Ren T, Zhang Y, Chen Z, Feng X, Sun L. Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China[J]. Clin Rheumatol. 2016;35(6):1521\u20137.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"13149_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0753-3322(01)00147-0","volume":"56","author":"EP Sampaio","year":"2002","unstructured":"Sampaio EP, Hernandez MO, Carvalho DS, Sarno EN. Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro[J]. Biomed Pharmacother. 2002;56(1):13\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"13149_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000331577","volume":"223","author":"TP Andersen","year":"2011","unstructured":"Andersen TP, Fogh K. Thalidomide in 42 patients with prurigo nodularis Hyde[J]. Dermatology. 2011;223(2):107\u201312.","journal-title":"Dermatology"},{"issue":"12","key":"13149_CR17","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/ijd.17327","volume":"63","author":"S Uzun","year":"2024","unstructured":"Uzun S, Durdu M, Y\u00fcrekli A, M\u00fclayim MK, Akyol M, Velipa\u015fao\u011flu S, Harman M, Taylan-\u00d6zkan A, \u015eavk E, Demir-Dora D, D\u00f6nmez L, Gazi U, Akta\u015f H, Akt\u00fcrk A, Demir G, G\u00f6ktay F, G\u00fcrel MS, G\u00fcrok NG, Karada\u011f AS, K\u00fc\u00e7\u00fck \u00d6S, Turan \u00c7, Ozden MG, Ural ZK, Zorbozan O, Mumcuo\u011flu KY. Clinical practice guidelines for the diagnosis and treatment of scabies[J]. Int J Dermatol. 2024;63(12):1642\u201356.","journal-title":"Int J Dermatol"},{"issue":"5","key":"13149_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2340\/00015555-1265","volume":"92","author":"A Reich","year":"2012","unstructured":"Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, Stander S, Szepietowski JC. Visual analogue scale: evaluation of the instrument for the assessment of pruritus[J]. Acta Derm Venereol. 2012;92(5):497\u2013501.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"13149_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/2229-5178.105486","volume":"4","author":"A Mittal","year":"2013","unstructured":"Mittal A, Garg A, Agarwal N, Gupta L, Khare AK. Treatment of nodular scabies with topical tacrolimus[J]. Indian dermatology online J. 2013;4(1):52\u20133.","journal-title":"Indian dermatology online J"},{"issue":"6","key":"13149_CR20","doi-asserted-by":"publisher","first-page":"e14163","DOI":"10.1111\/dth.14163","volume":"33","author":"Y Lu","year":"2020","unstructured":"Lu Y, Qi X, Zhou X, Chen X, Liu K, Yang Y, Mao Z, Wu Z, Zheng Y, Hu Y, Hu Y. Intralesional botulinum toxin A injection for treating nodular scabies[J]. Dermatol Ther. 2020;33(6):e14163.","journal-title":"Dermatol Ther"},{"issue":"6","key":"13149_CR21","doi-asserted-by":"publisher","first-page":"e13954","DOI":"10.1111\/dth.13954","volume":"33","author":"M Manjhi","year":"2020","unstructured":"Manjhi M, Yadav P, Mohan S, Sonthalia S, Ramesh V, Kashyap V. A comparative study of topical tacrolimus and topical triamcinolone acetonide in nodular scabies[J]. Dermatol Ther. 2020;33(6):e13954.","journal-title":"Dermatol Ther"},{"issue":"2","key":"13149_CR22","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.jaad.2017.03.034","volume":"77","author":"V Zawar","year":"2017","unstructured":"Zawar V, Pawar M. Liquid nitrogen cryotherapy in the treatment of chronic, unresponsive nodular scabies[J]. J Am Acad Dermatol. 2017;77(2):e43\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"13149_CR23","doi-asserted-by":"publisher","first-page":"204062232311956","DOI":"10.1177\/20406223231195632","volume":"14","author":"YK Zhao","year":"2023","unstructured":"Zhao YK, Lu JF, Liu JH, Wu HH, Song LL, Wan CL, Luo DQ. Recalcitrant nodular scabies showing excellent response to tofacitinib: five case reports[J]. Ther Adv Chronic Dis. 2023;14:20406223231195632.","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"13149_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0268-960X(02)00031-0","volume":"16","author":"K Strasser","year":"2002","unstructured":"Strasser K, Ludwig H. Thalidomide treatment in multiple myeloma[J]. Blood Rev. 2002;16(4):207\u201315.","journal-title":"Blood Rev"},{"issue":"3","key":"13149_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1470-2045(15)00559-8","volume":"17","author":"M Trneny","year":"2016","unstructured":"Trneny M, Lamy T, Walewski J, Belada D, Mayer J, Radford J, Jurczak W, Morschhauser F, Alexeeva J, Rule S, Afanasyev B, Kaplanov K, Thyss A, Kuzmin A, Voloshin S, Kuliczkowski K, Giza A, Milpied N, Stelitano C, Marks R, Trumper L, Biyukov T, Patturajan M, Bravo MC, Arcaini L. investigators St, in collaboration with the European Mantle Cell Lymphoma N. Lenalidomide versus investigator\u2019s choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial[J]. Lancet Oncol. 2016;17(3):319\u201331.","journal-title":"Lancet Oncol"},{"issue":"14","key":"13149_CR26","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1182\/blood-2011-01-330126","volume":"118","author":"P Fenaux","year":"2011","unstructured":"Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Canizo C, Guerci-Bresler A, Nilsson L, Platzbecker U, Lubbert M, Quesnel B, Cazzola M, Ganser A, Bowen D, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellstrom-Lindberg E, Group MDSLdqS. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-\/Intermediate-1-risk myelodysplastic syndromes with del5q[J]. Blood. 2011;118(14):3765\u201376.","journal-title":"Blood"},{"issue":"4","key":"13149_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1378\/chest.14-0015","volume":"146","author":"C Droitcourt","year":"2014","unstructured":"Droitcourt C, Rybojad M, Porcher R, Juillard C, Cosnes A, Joly P, Lacour JP, D\u2019Incan M, Dupin N, Sassolas B, Misery L, Chevrant-Breton J, Lebrun-Vignes B, Desseaux K, Valeyre D, Revuz J, Tazi A, Chosidow O, Dupuy A. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis[J]. Chest. 2014;146(4):1046\u201354.","journal-title":"Chest"},{"issue":"10","key":"13149_CR28","doi-asserted-by":"publisher","first-page":"e0008678","DOI":"10.1371\/journal.pntd.0008678","volume":"14","author":"B Upputuri","year":"2020","unstructured":"Upputuri B, Pallapati MS, Tarwater P, Srikantam A. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India[J]. PLoS Negl Trop Dis. 2020;14(10):e0008678.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"13149_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1592\/phco.23.4.481.32115","volume":"23","author":"MC Okafor","year":"2003","unstructured":"Okafor MC. Thalidomide for erythema nodosum leprosum and other applications[J]. Pharmacotherapy. 2003;23(4):481\u201393.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"13149_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/0961203305lu2124oa","volume":"14","author":"A Coelho","year":"2005","unstructured":"Coelho A, Souto MI, Cardoso CR, Salgado DR, Schmal TR, Waddington Cruz M, de Souza Papi JA. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients[J]. Lupus. 2005;14(6):434\u20139.","journal-title":"Lupus"},{"issue":"4","key":"13149_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2017.02.006","volume":"23","author":"D Millrine","year":"2017","unstructured":"Millrine D, Kishimoto T. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders[J]. Trends Mol Med. 2017;23(4):348\u201361.","journal-title":"Trends Mol Med"},{"issue":"2","key":"13149_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jaad.2015.09.039","volume":"74","author":"D Sharma","year":"2016","unstructured":"Sharma D, Kwatra SG. Thalidomide for the treatment of chronic refractory pruritus[J]. J Am Acad Dermatol. 2016;74(2):363\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"13149_CR33","doi-asserted-by":"crossref","unstructured":"Aguh C, Kwatra SG, He A, Okoye GA. Thalidomide for the treatment of chronic refractory prurigo nodularis[J]. Dermatol Online J. 2018;24(3).","DOI":"10.5070\/D3243038611"},{"issue":"11","key":"13149_CR34","first-page":"3349","volume":"7","author":"J Fujita","year":"2001","unstructured":"Fujita J, Mestre JR, Zeldis JB, Subbaramaiah K, Dannenberg AJ. Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2[J]. Clin Cancer Res. 2001;7(11):3349\u201355.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13149_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/000155500750012450","volume":"80","author":"BM Daly","year":"2000","unstructured":"Daly BM, Shuster S. Antipruritic action of thalidomide[J]. Acta Derm Venereol. 2000;80(1):24\u20135.","journal-title":"Acta Derm Venereol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13149-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13149-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13149-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:41:10Z","timestamp":1785112870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13149-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13149"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13149-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study involving a human participant was reviewed and approved by the Ethics committee of the First Affiliated Hospital of Kunming Medical University (approval No. 2018\u00a0L-45) and in accordance with the Declaration of Helsinki. The patient provided written informed consent to participate in this study. Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of the clinical details and\/or clinical images was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1393"}}